669 related articles for article (PubMed ID: 12604411)
21. TRAIL and apoptosis induction by TNF-family death receptors.
Wang S; El-Deiry WS
Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624
[TBL] [Abstract][Full Text] [Related]
22. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis.
He Q; Montalbano J; Corcoran C; Jin W; Huang Y; Sheikh MS
Oncogene; 2003 May; 22(17):2674-9. PubMed ID: 12730681
[TBL] [Abstract][Full Text] [Related]
23. Molecular signaling in death receptor and mitochondrial pathways of apoptosis (Review).
Gupta S
Int J Oncol; 2003 Jan; 22(1):15-20. PubMed ID: 12469180
[TBL] [Abstract][Full Text] [Related]
24. Fas and other cell death signaling pathways.
Depraetere V; Golstein P
Semin Immunol; 1997 Apr; 9(2):93-107. PubMed ID: 9194220
[TBL] [Abstract][Full Text] [Related]
25. Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction.
Koornstra JJ; Jalving M; Rijcken FE; Westra J; Zwart N; Hollema H; de Vries EG; Hofstra RW; Plukker JT; de Jong S; Kleibeuker JH
Eur J Cancer; 2005 May; 41(8):1195-202. PubMed ID: 15911244
[TBL] [Abstract][Full Text] [Related]
26. Modulation of TRAIL signaling for cancer therapy.
Fulda S; Debatin KM
Vitam Horm; 2004; 67():275-90. PubMed ID: 15110182
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor and trail interactions in epithelial-derived cells.
Gibson SB
Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae.
Martin S; Phillips DC; Szekely-Szucs K; Elghazi L; Desmots F; Houghton JA
Cancer Res; 2005 Dec; 65(24):11447-58. PubMed ID: 16357153
[TBL] [Abstract][Full Text] [Related]
29. Perturbation of the tumor necrosis factor--related apoptosis-inducing ligand cascade in ovarian cancer: overexpression of FLIPL and deregulation of the functional receptors DR4 and DR5.
Horak P; Pils D; Kaider A; Pinter A; Elandt K; Sax C; Zielinski CC; Horvat R; Zeillinger R; Reinthaller A; Krainer M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8585-91. PubMed ID: 16361541
[TBL] [Abstract][Full Text] [Related]
30. Autoamplification of apoptosis following ligation of CD95-L, TRAIL and TNF-alpha.
Herr I; Posovszky C; Di Marzio LD; Cifone MG; Boehler T; Debatin KM
Oncogene; 2000 Aug; 19(37):4255-62. PubMed ID: 10980599
[TBL] [Abstract][Full Text] [Related]
31. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells.
Lacour S; Micheau O; Hammann A; Drouineaud V; Tschopp J; Solary E; Dimanche-Boitrel MT
Oncogene; 2003 Mar; 22(12):1807-16. PubMed ID: 12660816
[TBL] [Abstract][Full Text] [Related]
33. Involvement of tumor necrosis factor-alpha receptor 1 and tumor necrosis factor-related apoptosis-inducing ligand-(TRAIL) receptor-2/DR-5, but not Fas, in graft injury in live-donor liver transplantation.
Tashiro H; Itamoto T; Ohdan H; Arihiro K; Tateaki Y; Nakahara H; Ochi M; Hino H; Mizunuma K; Hara H; Tokita D; Onoe T; Ishiyama K; Mitsuta H; Sugino K; Asahara T
Transpl Int; 2004 Nov; 17(10):626-33. PubMed ID: 15502938
[TBL] [Abstract][Full Text] [Related]
34. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
35. Apo2L/TRAIL and its death and decoy receptors.
LeBlanc HN; Ashkenazi A
Cell Death Differ; 2003 Jan; 10(1):66-75. PubMed ID: 12655296
[TBL] [Abstract][Full Text] [Related]
36. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
[TBL] [Abstract][Full Text] [Related]
37. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
[TBL] [Abstract][Full Text] [Related]
38. Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling.
El-Deiry WS
Cell Death Differ; 2001 Nov; 8(11):1066-75. PubMed ID: 11687885
[TBL] [Abstract][Full Text] [Related]
39. Death receptors in chemotherapy and cancer.
Debatin KM; Krammer PH
Oncogene; 2004 Apr; 23(16):2950-66. PubMed ID: 15077156
[TBL] [Abstract][Full Text] [Related]
40. Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases.
Saitou Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Hum Pathol; 2005 Oct; 36(10):1066-73. PubMed ID: 16226105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
